PneumoDose is a veteran-owned aerosol technology company founded by a team of scientists with over 70 years of combined experience in biomedical research. We strive to bring advanced aerosol capabilities to preclinical inhalational drug studies. PneumoDose’s unique expertise and technologies can significantly reduce the time and investment required for our customers to generate high-quality data sets to support inhalational drug development.
Helping our customers get their products to market.
PneumoDose partners with pharmaceutical contract research organizations to provide advanced aerosol services to our customers. We make it easier, faster, and less expensive to commercialize inhalational drug products.
Our team is also working to license advanced aerosol delivery and testing technology from the United States Government for commercial use. Keep in touch for more information regarding this exciting development.